Neurizon Therapeutics Ltd (NUZ)

Currency in AUD
0.082
-0.003(-3.53%)
Closed·
NUZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0820.085
52 wk Range
0.0750.185
Key Statistics
Bid/Ask
0.082 / 0.083
Prev. Close
0.085
Open
0.085
Day's Range
0.082-0.085
52 wk Range
0.075-0.185
Volume
607.15K
Average Volume (3m)
529.85K
1-Year Change
-31.6667%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.280
Upside
+241.46%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.280
(+241.46% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
24-02-2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
5.97M / --
EPS Revisions
Last 90 days

NUZ Income Statement

Compare NUZ to Peers and Sector

Metrics to compare
NUZ
Peers
Sector
Relationship
P/E Ratio
−4.1x−7.0x−0.5x
PEG Ratio
−0.370.030.00
Price/Book
7.3x3.3x2.6x
Price / LTM Sales
10.2x17.6x3.2x
Upside (Analyst Target)
229.4%180.0%50.8%
Fair Value Upside
Unlock−5.3%7.7%Unlock

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.

Employees
4
Market
Australia

FAQ

What Is the Neurizon Therapeutics (NUZ) Share Price Today?

The Neurizon Therapeutics share price today is 0.082.

What is the current Neurizon Therapeutics (NUZ) share price and day range?

As of 30-04-2026, the Neurizon Therapeutics share price is 0.082, with a previous close of 0.085. The share price has ranged from 0.082 to 0.085 today, while the 52-week range spans from 0.075 to 0.185.

What Is the Neurizon Therapeutics Market Cap?

As of today, Neurizon Therapeutics market cap is 60.850M.

What Is the Neurizon Therapeutics (NUZ) Share Price Target?

The average 12-month share price target for Neurizon Therapeutics is 0.280, with a high estimate of 0.28 and a low estimate of 0.28. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +241.46% Upside potential.

What Is Neurizon Therapeutics's Earnings Per Share (TTM)?

The Neurizon Therapeutics EPS (TTM) is -0.030.

From a Technical Analysis Perspective, Is NUZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Neurizon Therapeutics Trade On?

Neurizon Therapeutics is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Neurizon Therapeutics?

The stock symbol for Neurizon Therapeutics is "NUZ."

How Many Times Has Neurizon Therapeutics Stock Split?

Neurizon Therapeutics has split 6 times.

How Many Employees Does Neurizon Therapeutics Have?

Neurizon Therapeutics has 4 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.